Matzner Ulrich, Breiden Bernadette, Schwarzmann Günter, Yaghootfam Afshin, Fluharty Arvan L, Hasilik Andrej, Sandhoff Konrad, Gieselmann Volkmar
Institut für Physiologische Chemie and LIMES, Membrane Biology and Lipid Biochemistry Unit, c/o Kekulé-Institut für Organische Chemie und Biochemie, Rheinische Friedrich-Wilhelms-University, 53115 Bonn, Germany.
J Biol Chem. 2009 Apr 3;284(14):9372-81. doi: 10.1074/jbc.M809457200. Epub 2009 Feb 18.
Arylsulfatase A (ASA) catalyzes the intralysosomal desulfation of 3-O-sulfogalactosylceramide (sulfatide) to galactosylceramide. The reaction requires saposin B (Sap B), a non-enzymatic proteinaceous cofactor which presents sulfatide to the catalytic site of ASA. The lack of either ASA or Sap B results in a block of sulfatide degradation, progressive intralysosomal accumulation of sulfatide, and the fatal lysosomal storage disease metachromatic leukodystrophy. We studied the coupled Sap B-ASA reaction in vitro using detergent-free micellar and liposomal assay systems and in vivo using cell culture models of metachromatic leukodystrophy. Under in vitro conditions, the reaction had a narrow pH optimum around pH 4.3 and was inhibited by mono- and divalent cations, phosphate and sulfite. Bis(monoacylglycero) phosphate and phosphatidic acid were activators of the reaction, underscoring a significant role of acidic phosphoglycerolipids in sphingolipid degradation. Desulfation was negligible when Sap B was substituted by Sap A, C, or D. Up to a molar ratio between Sap B and sulfatide of 1:5, an elevation of Sap B concentrations caused a sharp increase of sulfatide hydrolysis, indicating the requirement of unexpected high Sap B levels for maximum turnover. Feeding of ASA-deficient, sulfatide-storing primary mouse kidney cells with ASA caused partial clearance of sulfatide. Co-feeding of Sap B or its precursor prosaposin resulted in the lysosomal uptake of the cofactor but did not promote ASA-catalyzed sulfatide hydrolysis. This suggests that Sap B is not a limiting factor of the coupled Sap B-ASA reaction in mouse kidney cells even if sulfatide has accumulated to unphysiologically high levels.
芳基硫酸酯酶A(ASA)催化3 - O - 硫酸半乳糖神经酰胺(硫脂)在溶酶体内脱硫酸生成半乳糖神经酰胺。该反应需要鞘脂激活蛋白B(Sap B),它是一种非酶蛋白辅因子,可将硫脂呈递给ASA的催化位点。缺乏ASA或Sap B都会导致硫脂降解受阻,硫脂在溶酶体内逐渐积累,进而引发致命的溶酶体贮积病——异染性脑白质营养不良。我们使用无去污剂的胶束和脂质体检测系统在体外研究了Sap B - ASA偶联反应,并使用异染性脑白质营养不良的细胞培养模型在体内进行了研究。在体外条件下,该反应在pH 4.3左右有较窄的最适pH值,且受到单价和二价阳离子、磷酸盐和亚硫酸盐的抑制。双(单酰甘油)磷酸酯和磷脂酸是该反应的激活剂,这突出了酸性磷酸甘油脂质在鞘脂降解中的重要作用。当Sap B被Sap A、C或D替代时,脱硫酸作用可忽略不计。在Sap B与硫脂的摩尔比达到1:5之前,Sap B浓度的升高会导致硫脂水解急剧增加,这表明需要意外的高Sap B水平才能实现最大周转率。用ASA喂养缺乏ASA且储存硫脂的原代小鼠肾细胞可使硫脂部分清除。同时喂食Sap B或其前体prosaposin会导致该辅因子被溶酶体摄取,但不会促进ASA催化的硫脂水解。这表明即使硫脂积累到非生理性高水平,Sap B在小鼠肾细胞的Sap B - ASA偶联反应中也不是限制因素。